Efficacy of Bismuth-Containing Quadruple Therapies for Clarithromycin-, Metronidazole-, and Fluoroquinolone-Resistant Helicobacter pylori Infections in a Prospective Study
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference26 articles.
1. Helicobacter pylori treatment in the era of increasing antibiotic resistance;Graham;Gut,2010
2. Treatment of Helicobacter pylori;Selgrad;Curr Opin Gastroenterol,2011
3. Second Asia-pacific consensus guidelines for Helicobacter pylori infection;Fock;J Gastroenterol Hepatol,2009
4. Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report;Malfertheiner;Gut,2012
5. Double-blind short-term trial of furazolidone in peptic ulcer;Zheng;Lancet,1985
Cited by 138 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Treatment failure is a key factor in the development of Helicobacter pylori resistance;Helicobacter;2024-05
2. Fourteen-day vonoprazan-based bismuth quadruple therapy for H. pylori eradication in an area with high clarithromycin and levofloxacin resistance: a prospective randomized study (VQ-HP trial);Scientific Reports;2024-04-18
3. Application of furazolidone in Helicobacter pylori infection eradication;Journal of Digestive Diseases;2024-03
4. Effectiveness of Rifabutin-Based Regimens in Treating Helicobacter pylori Infections;Cureus;2023-12-14
5. A Counterion‐Free Strategy for Chronic Metabolic Acidosis Based on an Orally Administered Gut‐Restricted Inorganic Adsorbent;Advanced Materials;2023-11-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3